Skip to main content

Toxicity Reporting Is Inconsistent and Incomplete, and Subjective Minimizing Language Is Common in Acute Leukemia Clinical Trials: A Systematic Review of Randomized Controlled Trials Presented at ASH between 2017-2021

Publication ,  Conference
Chin-Yee, B; Mohammed, T; Skorupski, C; Gyawali, B; Lyman, GH; Hicks, LK; Kuderer, DNMM
Published in: Blood
November 15, 2022

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 15, 2022

Volume

140

Issue

Supplement 1

Start / End Page

317 / 318

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chin-Yee, B., Mohammed, T., Skorupski, C., Gyawali, B., Lyman, G. H., Hicks, L. K., & Kuderer, D. N. M. M. (2022). Toxicity Reporting Is Inconsistent and Incomplete, and Subjective Minimizing Language Is Common in Acute Leukemia Clinical Trials: A Systematic Review of Randomized Controlled Trials Presented at ASH between 2017-2021. In Blood (Vol. 140, pp. 317–318). American Society of Hematology. https://doi.org/10.1182/blood-2022-157860
Chin-Yee, Benjamin, Turab Mohammed, Clarissa Skorupski, Bishal Gyawali, Gary H. Lyman, Lisa K. Hicks, and Dr Nicole M. M. Kuderer. “Toxicity Reporting Is Inconsistent and Incomplete, and Subjective Minimizing Language Is Common in Acute Leukemia Clinical Trials: A Systematic Review of Randomized Controlled Trials Presented at ASH between 2017-2021.” In Blood, 140:317–18. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-157860.
Chin-Yee, Benjamin, et al. “Toxicity Reporting Is Inconsistent and Incomplete, and Subjective Minimizing Language Is Common in Acute Leukemia Clinical Trials: A Systematic Review of Randomized Controlled Trials Presented at ASH between 2017-2021.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 317–18. Crossref, doi:10.1182/blood-2022-157860.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 15, 2022

Volume

140

Issue

Supplement 1

Start / End Page

317 / 318

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology